Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUET: TERN-501 Monotherapy and Combination with TERN-101 in NASH
NCT05415722Phase 2Completed
- Sponsor
- Terns Pharmaceuticals
- Start
- Jun 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TERN-501 in Nonalcoholic steatohepatitis (NASH), sponsored by Terns Pharmaceuticals. Started Jun 2022; status: completed.
02
Drugs
TERN-501
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT05415722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05415722.